Cargando…

CSE-1034 versus Ceftriaxone: Efficacy and Safety Analysis from a Randomized, Open-labeled Phase III Study in Complicated Urinary Tract Infections

OBJECTIVE: The aim of this study was to determine the clinical outcome, microbiological outcome and safety profile of CSE-1034, a novel combination of Ceftriaxone, Sulbactam and EDTA in patients with complicated urinary tract infections (cUTI). MATERIALS AND METHODS: This was a randomized, controlle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhary, Manu, Ayub, Shiekh Gazalla, Mir, Mohd Amin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276312/ https://www.ncbi.nlm.nih.gov/pubmed/30581259 http://dx.doi.org/10.4103/jgid.jgid_98_17

Ejemplares similares

Safety and efficacy of a novel drug elores (ceftriaxone + sulbactam + disodium edetate) in the management of multi-drug resistant bacterial infections in tertiary care centers: a post-marketing surveillance study
por: Chaudhary, Manu, et al.
Publicado: (2017)

1959. Ceftriaxone-Sulbactam-EDTA (CSE) vs. Meropenem (MR) in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes in Patients Infected With Ceftriaxone Non-Susceptible, Extended-Spectrum β-Lactamase and Multi-Drug-resistant Pathogens at Baseline
por: Mir, Mohd Amin, et al.
Publicado: (2018)

Protective role of ceftriaxone plus sulbactam with VRP1034 on oxidative stress, hematological and enzymatic parameters in cadmium toxicity induced rat model
por: Dwivedi, Vivek Kumar, et al.
Publicado: (2012)

1974. Ceftriaxone-Sulbactam-EDTA vs. Meropenem in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes by Baseline MIC in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis
por: Mandale, Pankaj, et al.
Publicado: (2018)

Ceftriaxone+Sulbactam+Disodium EDTA Versus Meropenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: PLEA, a Double-Blind, Randomized Noninferiority Trial
por: Mir, Mohd Amin, et al.
Publicado: (2019)

1984. Ceftriaxone-Sulbactam-EDTA vs. Meropenem: Analysis of Failed Patients With Assessment of MIC Increases and Changes in Genotypic Profile in PLEA (a Phase 3, Randomized, Double-Blind Clinical Trial in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis)
por: Mir, Mohd Amin, et al.
Publicado: (2018)

381. Effect of Ceftriaxone+sulbactam+disodium EDTA Combination in Treatment of Complicated Urinary Tract Infections Caused by Metallo Beta-lactamase Producing Enterobacterales: An Open Label Randomized Controlled Trial
por: Samantaray, Subhashree, et al.
Publicado: (2023)

Parameter Space Beyond “1034”
por: Zimmermann, F
Publicado: (2010)

Parameter Space Beyond 1034
por: Zimmermann, F
Publicado: (2010)

1034. Automating Assessments of Vancomycin Appropriateness
por: Holmer, Haley K, et al.
Publicado: (2019)

1373. Activity of Ceftriaxone–Sulbactam–EDTA Against Multi-Drug-resistant A. baumannii, P. aeruginosa and Enterobacteriaceae Isolates (WHO Critical Priority Pathogens) Collected from Various Hospitals in India
por: Girotra, Ruchi, et al.
Publicado: (2018)

Reduced nitrate level in individuals with hypertension and diabetes
por: Shiekh, Gazalla Ayub, et al.
Publicado: (2011)

P1034: HEALTHCARE UTILIZATION OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE
por: Hwee, J., et al.
Publicado: (2022)

CLIC CRAB CAVITY SPECIFICATIONS MILESTONE: M10.3.4
por: Ambattu, P, et al.
Publicado: (2010)

M10.3.4: CLIC crab cavity specifications completed
por: Dexter, A, et al.
Publicado: (2010)

PReS13-SPK-1034: looking for new monogenic forms of lupus
por: Crow, Y
Publicado: (2013)

1034. Risk Score for the Need of Mechanical Ventilation in Adults Presenting with Encephalitis.
por: Heck, Ashley N, et al.
Publicado: (2022)

Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection
por: Elajouz, Balsam, et al.
Publicado: (2022)

Urinary sludge caused by ceftriaxone in a young boy
por: Kimata, Takahisa, et al.
Publicado: (2012)

Phosphineoxide-Chelated Europium(III) Nanoparticles for Ceftriaxone Detection
por: Zairov, Rustem, et al.
Publicado: (2023)

Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial
por: Lojanapiwat, Bannakij, et al.
Publicado: (2019)

LHCb Upgrades and operation at 1034 cm-2 s-1 luminosity –A first study
por: Efthymiopoulos, Ilias, et al.
Publicado: (2018)

1034 Clinical Laboratory Practices in Speciating Organisms and Reporting Results of Voided Urine Cultures
por: Sfeir, Maroun, et al.
Publicado: (2014)

Acute Fascial Space Infections of the Neck: 1034 cases in 17 years follow up
por: Prabhu, Supreet Ratnakar, et al.
Publicado: (2019)

A retrospective study on sperm cryopreservation in 1034 patients diagnosed with cancer in southern China
por: Wang, Qi-Ling, et al.
Publicado: (2022)

A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections
por: Xin, Xiaojuan, et al.
Publicado: (2013)

A novel G26A variation in 5′ half of TGIF1 gene associates with high myopia in ethnic Kashmiri population from India
por: Rasool, Shabhat, et al.
Publicado: (2019)

Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial
por: Arjyal, Amit, et al.
Publicado: (2016)

Ceftriaxone: Cholelithiasis following off-label use: case report
Publicado: (2021)

Comparison of Ertapenem and Ceftriaxone Therapy for Acute Pyelonephritis and Other Complicated Urinary Tract Infections in Korean Adults: A Randomized, Double-Blind, Multicenter Trial
por: Park, Dae Won, et al.
Publicado: (2012)

2821. A Comparison of Empirical Therapy with Cefazolin Versus Ceftriaxone for the Treatment of Complicated Urinary Tract Infections in a Tertiary Care VA Medical Center
por: Carcamo, Paola, et al.
Publicado: (2023)

Homocysteine Triggers Inflammatory Responses in Macrophages through Inhibiting CSE-H(2)S Signaling via DNA Hypermethylation of CSE Promoter
por: Li, Jiao-Jiao, et al.
Publicado: (2015)

1034 Are socioeconomically disadvantaged pregnant patients disproportionally infected by SARS-CoV-2 virus?
por: Ndubizu, Chima, et al.
Publicado: (2021)

A Novel High Performance Liquid Chromatographic Method for Simultaneous Determination of Ceftriaxone and Sulbactam in Sulbactomax
por: Shrivastava, Sanjay Mohan, et al.
Publicado: (2009)

Ceftriaxone/heparin/hydroxychloroquine: Thrombocytopenia and off-label use: case report
Publicado: (2020)

Overview of key findings on CSE status in 4 countries
por: Ivanova, O
Publicado: (2023)

Antiamoebic Properties of Ceftriaxone and Zinc-Oxide–Cyclodextrin-Conjugated Ceftriaxone
por: Makhlouf, Zinb, et al.
Publicado: (2022)

Baricitinib/ceftriaxone/metoclopramide: Extrapyramidal syndrome and off label use: case report
Publicado: (2021)

Ceftriaxone/dexamethasone/immune-globulin: Hyperglycaemia and Off-label-use: case report
Publicado: (2021)

Ceftriaxone/hydroxychloroquine/lopinavir: Lack of efficacy in off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_psuj8qhcevjraa1vr58a1nka25